CV Sciences, Inc.
(Other OTC/NBB : CANV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading CANV News...
...
Consumer Services » Other Consumer Services
symbolcompany%chnglast%shortavg$volume
PCLNPriceline Group Inc
0.17%1649.802.6%$648.39m
EBAYeBay Inc.
-0.59%33.721.7%$386.57m
EXPEExpedia, Inc.
0.25%119.707.3%$235.56m
CTRPCtrip.com International Ltd Sponsored ADR
1.23%47.644.9%$152.99m
TRIPTripAdvisor, Inc.
-2.54%45.658.7%$121.06m
EDUNew Oriental Education & Technology Group, Inc. Sponsored ADR
0.79%49.561.3%$53.16m
HRBH&R Block, Inc.
-0.90%20.428.2%$52.28m
SCIService Corporation International
0.00%31.644.4%$43.84m
SERVServiceMaster Global Holdings Inc
0.36%38.814.2%$25.58m
DVDeVry Education Group Inc.
-0.46%32.7016.4%$25.16m
BIDSotheby's Class A
-1.07%40.6716.2%$18.08m
ROLRollins, Inc.
-0.38%36.724.2%$18.06m
LOPEGrand Canyon Education, Inc.
0.59%61.272.6%$17.13m
PLNTPlanet Fitness Inc Class A
-1.11%21.418.7%$16.82m
MMYTMakeMyTrip Ltd.
1.23%32.956.6%$16.73m

Company Profile

CV Sciences, Inc. is a life science company, which develops, produces, markets and sells raw materials and end consumer products containing the hemp plant extract, Cannabidiol (CBD) to the nutraceutical, beauty care, pet care, specialty beverage and functional food sectors. The company operates its business through two segments: Specialty Pharmaceuticals and Consumer Products. The Specialty Pharmaceuticals segment is focused on developing and commercializing novel therapeutics utilizing synthetic Cannabidiol. The Consumer Products segment engages in the manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The company was founded by H. J. Cole on December 9, 2010 and is headquartered in Las Vegas, NV.